Top compounds associated with response to ADGRG2


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.042 0.4
mRNA tivozanib CTRPv2 pan-cancer AAC -0.027 0.5
mRNA tivozanib GDSC1000 pan-cancer AAC -0.015 0.7
mRNA tosedostat CTRPv2 pan-cancer AAC -0.022 0.6
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0061 0.9
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.6
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.0021 0.9
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.076 0.05
mRNA triptolide CTRPv2 pan-cancer AAC 0.018 0.6
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.043 0.4
Download CSV